echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Brain: Neuroimaging features of brain injury in Wilson's disease—a multimodal whole-brain MRI study

    Brain: Neuroimaging features of brain injury in Wilson's disease—a multimodal whole-brain MRI study

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Wilson's disease is an autosomal recessive disorder of copper metabolism with neurological and hepatic abnormalities
    .


    Neuroimaging studies have uncovered a range of abnormal outcomes that increase the understanding of disease mechanisms and provide a research pathway
    for disease prognosis and biomarkers that can be used for detection.


    However, previous quantitative MRI analyses have focused only on a particular sequence or region of interest and have often stratified
    chronically treated patients based on ongoing symptoms rather than initial symptoms.


    Results of the study

    In this cross-sectional prospective study, we recruited 40 patients with Wilson's disease (ages 16-68 years)
    using unbiased whole-brain T1-weighted imagery, FLAIR imagery, DWI, and SWI analysis.


    In addition, we subgroup patients based on current symptomatic status, defining patients with neurological manifestations or deterioration in the past 6 months as having an "active type"
    .


    By combining voxel-based morphological analysis (VBM) and volumetric analysis of the region of interest, we found that the volume of gray matter is small
    in the basal ganglion, thalamus, brainstem, cerebellum, anterior thalamus, and orbitofrontal cortex.


    Fig.


    Calculations using the automatic lesion segmentation algorithm showed no correlation between disease severity and white matter hypersignal (WMHs) volume (Figure 2).


    Fig.


    Using spatial statistical analysis based on fibrous bundles, an increase in the severity of the condition in chronically treated patients was associated with a decrease in the axial diffusion rate of the leukofibrous bundle and that there was an increase
    in serum non-cyanoplasmin-bound (free) copper.


    Figure 3 Disease states
    based on fiber bundle spatial statistics.


    Quantitative susceptibility mapping analysis of the whole brain found that patients with neurological manifestations had iron deposition in the shell core, cingulate gyrus and medial frontal cortex; In patients with chronic treatment, the severity of neurological symptoms is associated with extensive iron deposition in the cortical region (Figure 4
    ).


    Figure 4 Results
    of the whole brain quantitative magnetic sensitivity map.


    Taken together, our data suggest that a composite indicator of subcortical atrophy provides an effective biomarker for predicting the condition, while abnormal average, axial, and radial spread rates are potential biomarkers
    for monitoring the condition.


    Finally, iron deposition in the brain associated with copper accumulation may directly lead to neurodegenerative lesions
    in Wilson's disease.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.